Page last updated: 2024-10-31
nafamostat and Diseases, Peripheral Vascular
nafamostat has been researched along with Diseases, Peripheral Vascular in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Urabe, Y | 1 |
Ideishi, M | 1 |
Sasaguri, M | 1 |
Ikeda, M | 1 |
Arakawa, K | 1 |
Kizaki, Y | 1 |
Ueki, Y | 1 |
Yoshida, K | 1 |
Yano, M | 1 |
Matsumoto, K | 1 |
Miyake, S | 1 |
Tominaga, Y | 1 |
Eguchi, K | 1 |
Yano, K | 1 |
Trials
1 trial available for nafamostat and Diseases, Peripheral Vascular
Article | Year |
---|---|
Beneficial effects of a serine protease inhibitor in peripheral vascular disease.
Topics: Aged; Arteriosclerosis Obliterans; Benzamidines; Chronic Disease; Exercise Test; Female; Femoral Vei | 1993 |
Other Studies
1 other study available for nafamostat and Diseases, Peripheral Vascular
Article | Year |
---|---|
Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Benzamidines; Blood Component Removal; Bradykinin | 1999 |